Verve Therapeutics

261 people · 10 jobs
‌

Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Employees

201-500

Links


Org chart

Hiring!

Sekar Kathiresan
Co-Founder & CEO
Collapse
Barry Ticho
Co-Founder
Andrew Ashe
President & COO
Troy Lister
SVP, Research
Joe Biedenkapp
VP, Editing Development
Victor Farutin
Senior Director, Computational Biology
Praveen Prasanna
Senior Director, External Manufacturing
Ann Dougherty
Executive Director, Medical Writing
William Toth
Director, Clinical Data Management
Caitlin Moreno
Senior Manager, Environmental, Health & Safety
Steve Briscoe
Senior Medical Writer
Alexandra Chadwick
Director, Editing & Discovery
Emily Donlon
Senior Director, Information Technology
Leslie Stolz
SVP, Regulatory Affairs

Board & advisors

Burt Adelman
Chairman
Bo Cumbo
Director
Issi Rozen
Strategic Advisor
Anthony Philippakis
Scientific Advisor
Kiran Musunuru
Scientific Advisor
Andrew Geall
Scientific Advisor
Daniel J. Rader
Scientific Advisor
Eugene Braunwald
Scientific Advisor
Penny M. Heaton
Scientific Advisor